Histoplasmosis presenting as cellulitis 18 years after renal transplantation

Medical Mycology

Volumn 46, Issue 7, 2008, Pages 725-728

  Marques, Silvio ^a   Hozumi, Silvia ^a   Camargo, Roŝangela ^a   Carvalho, Maria Fernanda ^a   Marques, Mariangela E A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cellulitis; Histoplasmosis; Itraconazole; Renal transplantation

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CEFTRIAXONE; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; BACTERIAL SKIN DISEASE; CASE REPORT; CELLULITIS; CHRONIC GLOMERULONEPHRITIS; CLINICAL FEATURE; EPITHELIUM HYPERPLASIA; FEMALE; FEVER; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALAISE; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; SKIN BIOPSY; SKIN DEFECT; SKIN INFECTION; TREATMENT DURATION;

CELLULITIS; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; KIDNEY TRANSPLANTATION; MIDDLE AGED; TREATMENT OUTCOME;

AJELLOMYCES CAPSULATUS;

EID: 55149096596     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802247736     Document Type: Article

References (27)

1. Sweny, P. and Burroughs, AK. (1994) Infections in solid organ transplantation. Curr Opin Infect Dis, 7, pp. 436-443.
2. Miller, LW, Naftel, DC Bourge, RC et al. (1994) and the Cardiac Transplant Research Database Group. Infection after heart transplantation: A multiinstitutional study. J Heart Lung Transplant, 13, pp. 381-392.
3. Cano, MVC and Hajjen, RA. (2001) The epidemiology of histoplasmosis: A review. Semin Respir Infect, 16, pp. 109-118.
4. Wheat, LJ, Slama, TG Norton, JA et al. (1982) Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med, 96, pp. 159-163.
5. Wong, SY and Allen, DM. (1992) Transmission of disseminated histoplasmosis via cadaveric renal transplantation: Case report. Clin Infect Dis, 14, pp. 232-234.
6. Kauffman, CA, Israel, KE Smith, JW et al. (1978) Histoplasmosis in immunosuppressed patients. Am J Med, 64, pp. 923-932.
7. Goodwin Jr, RA, Shapiro, JL Thurman, GH et al. (1980) Disseminated histoplasmosis: Clinic and pathologic correlations. Medicine, 59, pp. 1-33.
8. Wheat, L. (1996) Histoplasmosis in the acquired immunodeficiency syndrome. Curr Topics Med Mycol, 7, pp. 7-18.
9. Lee, JH, Slifman, NR Gershon, SK et al. (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximabe and etanercept. Arthritis Rheum, 46, pp. 2565-2570.
10. Peddi, VR, Hariharan, S. and First, MR. (1996) Disseminated histoplasmosis in renal allograft recipients. Clin Transplant, 10, pp. 160-165.
11. Wheat, LJ, Smith, EJ Sathapatayavongs, B. et al. (1983) Histoplasmosis in renal allograft recipients: Two large urban outbreaks. Arch Intern Med, 143, pp. 703-707.
12. Vail, GM, Young, RS Wheat, LJ et al. (2002) Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis, 4, pp. 148-151.
13. Delfino, VDA, Matni, AM, Gordan, PA and Mocelin, AJ. (1994) Micoses profundas em transplantados renais: Indicacao de alerta clinico. J Bras Nefrol, 16, pp. 143-148.
14. Uip, DE, Amato Neto, V Strabelli, MV et al. (1996) Infeccoes fungicas em 100 pacientes submetidos a transplante cardiaco. Arq Bras Cardiol, 66, pp. 65-67.
15. Bacal, F., Andrade, ACM Migueletto et al. (2001) Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas disease. Arq Bras Cardiol, 76, pp. 406-408.
16. Marques, SA, Robles, M. Tortorano, AM et al. (2000) Mycosis associated with AIDS in the third world. Med Mycol, 38, pp. 269-279.
17. Wheat, LJ, Connoly-Striengfield, PA Baker, RL et al. (1990) Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature. Medicine, 69, pp. 361-374.
18. Tobon, AM, Agudelo, CA Rosero, DS et al. (2005) Disseminated histoplasmosis: A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg, 73, pp. 576-582.
19. Chang, MR, Taira, CL Paniago, AMM et al. (2007) Study of 30 cases of histoplasmosis observed in Mato Grosso do Sul state, Brazil. Rev Inst Med Trop S Paulo, 49, pp. 37-39.
20. Motta, ACF, Galo, R. Lourenco, AG et al. (2006) Unusual orofacial manifestation of histoplasmosis in renal transplanted patient. Mycopathologia, 161, pp. 161-165.
21. McGuinn, ML, Lawrence, LP and Segreti, J. (2005) Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. J. Transplant Proc, 37, pp. 4313-4314.
22. Pasqualoto, AC, Bittar, AEN, Quadros, M. and Severo, LC. (2005) Cryptococcal cellulitis in a renal transplant patient. Nephrol Dial Transplant, 20, pp. 2007-2008.
23. Van Grieeken, SAH, Dupont, LJ, Van Raemdonck, DEM, Van Bleyenbergh, P. and Verleden, GM. (2007) Primary cryptococcal cellulitis in a lung transplant patient. J Heart Lung Transplant, 26, pp. 285-289.
24. Wheat, LJ, Freifeld, AG Kleiman, MB et al. (2007) Clinical practice guideline for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis, 45, pp. 807-825.
25. Espinel-Ingroff, A. (1998) Comparison of in vitro activities of the new triazole SCH 56592 and the echinocandins MK-0991(- 743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol, 36, pp. 2950-2956.
26. Connoly, P., Wheat, LJ Schnizlein-Bick, C. et al. (2000) Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother, 44, pp. 2604-2608.
27. Restrepo, A., Tobon, A. Clark, B. et al. (2007) Salvage treatment of histoplasmosis with posaconazole. J Infect, 54, pp. 319-327.